Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ALBIREO PHARMA, INC. | albo-ex321_238.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_239.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_240.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | albo-ex211_242.htm |
| EX-10.15 - EX-10.15 - ALBIREO PHARMA, INC. | albo-ex1015_447.htm |
| EX-10.14 - EX-10.14 - ALBIREO PHARMA, INC. | albo-ex1014_444.htm |
| EX-10.13 - EX-10.13 - ALBIREO PHARMA, INC. | albo-ex1013_443.htm |
| EX-10.10.4 - EX-10.10.4 - ALBIREO PHARMA, INC. | albo-ex10104_441.htm |
| EX-10.9.3 - EX-10.9.3 - ALBIREO PHARMA, INC. | albo-ex1093_442.htm |
| EX-10.7 - EX-10.7 - ALBIREO PHARMA, INC. | albo-ex107_440.htm |
| EX-4.1 - EX-4.1 - ALBIREO PHARMA, INC. | albo-ex41_445.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20160930.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Albireo Pharma, Inc. (f/k/a Biodel Inc.)
Boston, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-144407, 333-168903 and 333-180409) of Albireo Pharma, Inc. (formerly Biodel Inc.) of our report dated December 22, 2016, relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K.
/s/ BDO USA, LLP
BDO USA, LLP
New York, New York
December 22, 2016